Jeff Bezos started Amazon in his garage with a couple hundred grand from his parents. This ex-hedge fund manager turned internet titan and evil king-making gnome has often been lauded for his customer-focused business strategies, aggressive business development and industry prowess, but how challenging is the journey when you’re a 1500lb gorilla on someone else’s dime?
Ever since the greasy arrogant squirrel-faced grin of Martin Shkreli turned our collective stomach, big pharma has come under fire for their pricing practices. Pharma execs, often paid up to 300 times more than their average employee, shot back that research and development costs were crippling and all that needed to be paid for with healthy profit margins. Should we just buck up and shut up, or are we witnessing the brain death of big pharma?
Remember Han Christian Andersen’s The Emperor’s New Clothes? It starts off about seeing something and saying nothing, but then ends with deliberate denial. It seemed as though Anderson’s satire came to life when analysts proclaimed retailers would enjoy a busy Christmas because the latest consumer sentiment index (CSI) was up.
When Slack (WORK) listed on the NYSE this year, it was the first tech unicorn to grace American markets through a direct listing rather than the traditional Initial Public Offering (IPO). This historic event came on the heels of a growing dissatisfaction in Silicon Valley over Wall Street’s preferred path to public trading.
Equity.Guru podcast: A Closer Look – Rare earth metals miner, Defense Metals (DEFN.V), proving out impressive chemistry at BC property
Rare earth metals were little known before 1960, but in the sixty years since, it has become the foundation for our technologically driven society. You can find rare earth metals in nearly everything electronic from rechargeable batteries to missile guidance systems. There are no substitutes and if there is any supply chain squeezes, the manufacturing of all those convenient and necessary devices that make our life modern, would promptly grind to a halt.
Equity.Guru podcast – A Closer Look: Azincourt Energy (AAZ.V) turning Athabasca uranium project into gold
Uranium is volatile both atomically and as a commodity. Currently pricing has hit a low, but its not bottomed out and external pressures from a declining supply and increasing demand, could see this nuclear fuel spike on the boards within the next year. This bodes well for Athabasca uranium.